Effects of Inhaled Amitriptyline on Airway Function and Immune Responses in Experimental Asthma
Advances in Respiratory Medicine · 06.08.2026 · 94 (4) · 58
DOI: 10.3390/arm94040058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 06.08.2026. Verfasst von Anna Michely und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Medical Faculty, RWTH Aachen, University Hospital Aachen, 52074 Aachen, Germany. Hauptthemen laut MEDLINE: Amitriptyline, Asthma. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Research Foundation.
Abstract (Originalsprache)
Background
Bronchial asthma is a chronic inflammatory airway disease characterized by acute bronchoconstriction and type 2-driven inflammation. This study investigated whether inhaled amitriptyline, a functional inhibitor of acid sphingomyelinase, exerts both bronchodilatory and immunomodulatory effects in experimental murine models of allergic airway inflammation (AAI) and human cellular systems.
Methods
Acute AAI was induced in mice using ovalbumin (OVA) and house dust mite (HDM) protocols, respectively. Inhaled amitriptyline (3.3 mg/mL) was administered for either 20 days (short-term) or 36 days (long-term). Lung function was assessed using FlexiVent®, and inflammatory markers including IgE, eosinophils, and type 2 cytokines were measured in bronchoalveolar lavage fluid and lung tissue. Complementary experiments were included using passively sensitized PCLSs and human type 2-differentiated CD4+ T cells.
Results
Inhaled amitriptyline improved lung mechanics in both the OVA and HDM models, reducing total respiratory resistance and elastance. In the OVA model, eosinophil and T cell counts in BALF were decreased, whereas immunomodulatory effects were less pronounced in the short-term HDM model. In human TH2 cells, no significant changes in cytokine production or gene expression were observed. Ex vivo, amitriptyline dose-dependently inhibited allergen-induced bronchoconstriction in PCLSs.
Conclusions
Inhaled amitriptyline improves lung function across murine models of AAI, supporting its potential in exhibiting model-dependent immunomodulatory effects, and directly attenuates allergen-induced bronchoconstriction, supporting its potential as a bronchodilator with context-dependent immunomodulatory properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Medical Faculty, RWTH Aachen, University Hospital Aachen, 52074 Aachen, Germany.
- Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen, University Hospital Aachen, 52074 Aachen, Germany.
ORCID-Profile: Klaus Tenbrock
Förderung
- Deutsche Forschungsgemeinschaft
- German Research Foundation
Zitieren
APA
Michely, A., Böll, S., Yao, L., Ben Hamza, R., Rachimow, I., Tenbrock, K., Martin, C., & Verjans, E. (2026). Effects of Inhaled Amitriptyline on Airway Function and Immune Responses in Experimental Asthma. Advances in Respiratory Medicine, 94(4), 58. https://doi.org/10.3390/arm94040058
Vancouver
Michely A, Böll S, Yao L, Ben Hamza R, Rachimow I, Tenbrock K, et al. Effects of Inhaled Amitriptyline on Airway Function and Immune Responses in Experimental Asthma. Advances in Respiratory Medicine. 2026;94(4):58. doi:10.3390/arm94040058
BibTeX
@article{Michely2026,
author = {Michely, Anna and Böll, Svenja and Yao, Lida and Ben Hamza, Regina and Rachimow, Irina and Tenbrock, Klaus and Martin, Christian and Verjans, Eva},
title = {Effects of Inhaled Amitriptyline on Airway Function and Immune Responses in Experimental Asthma},
journal = {Advances in Respiratory Medicine},
year = {2026},
volume = {94},
number = {4},
pages = {58},
doi = {10.3390/arm94040058}
}
EUVIMED